CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | Aspiri Ray Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-05-20 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise | +36,856 | $4.10 | $151K | 2,063,842 |
| 2021-05-20 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Sale | −36,856 | $14.96 | $551K | 2,026,986 |
| 2021-05-20 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise · Stock Option (right to buy) | −36,856 | 73,713 | ||
| 2021-05-19 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise | +36,857 | $4.10 | $151K | 2,063,843 |
| 2021-05-19 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Sale | −36,857 | $17.07 | $629K | 2,026,986 |
| 2021-05-19 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise · Stock Option (right to buy) | −36,857 | 110,569 | ||
| 2021-04-08 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise | +35,206 | $4.10 | $144K | 2,062,192 |
| 2021-04-08 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Sale | −35,206 | $17.76 | $625K | 2,026,986 |
| 2021-04-08 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise · Stock Option (right to buy) | −35,206 | 147,426 | ||
| 2021-04-07 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise | +37,407 | $4.10 | $153K | 2,064,393 |
| 2021-04-07 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Sale | −37,407 | $17.91 | $670K | 2,026,986 |
| 2021-04-07 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise · Stock Option (right to buy) | −37,407 | 182,632 | ||
| 2021-02-22 | Demopulos Peter A MD Director | Option exercise | +5,000 | $5.30 | $27K | 193,516 |
| 2021-02-22 | Demopulos Peter A MD Director | Option exercise | +5,000 | $4.53 | $23K | 198,516 |
| 2021-02-22 | Demopulos Peter A MD Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2021-02-22 | Demopulos Peter A MD Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2021-02-22 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise | +8,100 | $10.27 | $83K | 22,100 |
| 2021-02-22 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Sale | −8,100 | $23.28 | $189K | 14,000 |
| 2021-02-22 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise · Stock Option (right to buy) | −8,100 | 65,000 |
Page 8 of 9 · 178 trades